The Usefulness of C-Reactive Protein, Procalcitonin, and PELOD-2 Score as a Predictive Factor of Mortality in Sepsis

Munar Lubis, Aridamuriany Dwiputri Lubis, Badai Buana Nasution


BACKGROUND: Sepsis in children is a significant cause of morbidity and mortality in the pediatric intensive care unit (PICU). Assessment of pediatric sepsis using serial Pediatric Logistic Organ Dysfunction (PELOD)-2 score can be used as a prognostic factor. The use of biomarkers of sepsis is also used for diagnosis and predicting outcomes. Many studies have suggested that C-reactive protein (CRP) and procalcitonin (PCT) can be used to predict mortality.

METHODS: A prospective cohort study was conducted to evaluate CRP, PCT, PELOD-2 score and its combination as a predictive factor of mortality in sepsis. All patients admitted to PICU Haji Adam Malik General Hospital, Medan, from April to November 2019 with suspected sepsis were included in this study. Blood examination and PELOD-2 scores were examined in the first 24 hours.

RESULTS: A total of 79 children were included with a mortality rate 55.7%. The CRP, PCT, and PELOD-2 score were higher in nonsurvivor (2.8 (0.5-22.4) mg/dL; 9.36 (0.13-79.8) ng/mL; 9 (3-21), respectively). In multivariate logistic regression analysis, neither CRP nor PCT values could be independent predictors of mortality. The PELOD-2 score can be an independent predictor for mortality at a cut-off score of 7 (OR: 3.47 (95% CI: 1.68-7.19)). The combination of PELOD-2 and CRP scores as predictors of mortality showed lower values than PELOD-2 and PCT scores (0.80 vs. 0.95). The combination of all parameters only adds 1% of the predicted mortality value.

CONCLUSION: PELOD-2 score with PCT value are recommended to predict mortality children with sepsis.

KEYWORDS: sepsis, mortality, C-reactive protein, procalcitonin, PELOD-2 score

Full Text:



Khan MR, Maheshwari PK, Masood K, Qamar FN, Haque AU. Epidemiology and outcome of sepsis in a tertiary care PICU of Pakistan. Indian J Pediatr. 2012; 79: 1454-8, CrossRef.

Weiss SL, Fitzgerald JC, Maffei FA. Discordant identification of pediatric severe sepsis by research and clinical definition in the SPROUT international point prevalence study. Crit Care. 2015; 19: 325-34, CrossRef.

Proulx F, Fayon M, Farell CA, Lacroix J, Guthier M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. CHEST. 2006; 109: 1033-7, CrossRef.

Saraswati DD, Pudjiadi AH, Djer MM, Supriyatno B, Syarif DR, Kurniati N. Faktor risiko yang berperan pada mortalitas sepsis. Sari Pediatri. 2014; 15: 281-8, CrossRef.

Salim E, Lubis M, Ali M. Hubungan antara Nilai troponin T dan mortalitas pada anak syok sepsis yang dirawat di PICU [Thesis]. Medan: Universitas Sumatera Utara; 2014, article.

Singer M, Deutchman CS, Seymour CW, Shankar-Hari M, Annane D, Baurer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 801-10, CrossRef.

Chun K, Syndergaard C, Damas C, Trubey R, Mukindaraj A, Qian S, et al. Sepsis pathogen identification. J Lab Automation. 2015; 20: 539-61, CrossRef.

Leteurtre S, Duhamel A, Deken V, Lacroix J, Leclerc F. Daily estimation of the severity organ dysfunctions in critically ill children by using the PELOD-2 score. Crit Care. 2015; 19: 324, CrossRef.

Sharma D, Farahbakhsh N, Shastri S, Sharma P. Biomarkers for diagnosis of neonatal sepsis: a literature review. J Matern Fetal Neonatal Med. 2018; 31: 1646-59, CrossRef.

Siddiqui I, Jafri L, Abbas Q, Raheem A, Haque AU. Serum procalcitonin, C-reactive protein and lactic acid to organ failure and outcome in critically ill pediatric population. Indian J Crit Care Med. 2018; 22: 91-5, CrossRef.

Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013; 50: 23-36, CrossRef.

Vijayan AL, Vanimaya, Ravindran S, Saikant R, Lakshmi S, Kartik R, et al. Procacitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017; 5: 51, CrossRef.

Lanziotti VS, Povoa P, Soares M, Silva JRL, Barbosa AP, Salluh JIF. Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva. 2016; 28: 462-82, CrossRef.

Wang Y, Sun B, Yue H, Li B, Yang X, Shan C, et al. An epidemiologic survey of pediatric sepsis in regional hospitals in China. Pediatr Crit Care Med. 2014; 15: 814-20, CrossRef.

Jaramillo-Bustamante JC, Marin-Agudelo A, Fernandez-Laverde M, Bareno-silva J. Epidemiology of sepsis in pediatric intensive care units: first Columbian multicentre study. Pediatr Crit Care Med. 2012; 13: 501-8, CrossRef.

Karam O, Demaret P, Duhamel A, Shefler A, Spinella PC, Stanworth SJ, et al. Performance of the Pediatric Logistic Organ Dysfunction-2 score in critically ill children requiring plasma transfusions. Ann Intensive Care. 2016; 6: 98, CrossRef.

Marshall JC, Reinhart K. Biomarkers of sepsis. Crit Care Med. 2009; 37: 2290-8, CrossRef.

Coelho LM, Salluh JI, Soares M, Bozza FA, Verdeal JC, Castro-Faria-Neto HC. Patterns of c-reactive protein ratio response in severe community-acquired pneumonia: a cohort study. Crit Care. 2012; 16: R53, CrossRef.

Horvat CM, Bell J, Kantawala S, Au AK, Clark RS, Carcillo JA. C-reactive protein and ferritin are associated with organ dysfunction and mortality in hospitalized children. Clin Pediatr. 2019; 58: 752-60, CrossRef.

Memar MY, Varshochi M, Shokouhi B, Asgharzadeh M, Kafil HS. Procalcitonin: the marker of pediatric bacterial infection. Biomed Pharmacother. 2017; 96: 936-43, CrossRef.

Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med. 2000; 28; 2591-4, CrossRef.

Wu Q, Nie J, Wu F, Xou X, Chen F. Prognostic value of highsensitivity C-Reactive Protein, procalcitonin, and pancreatic stone protein in pediatric sepsis. Med Sci Monit. 2017; 23: 1533-9, CrossRef.

Nakamura M, Kono R, Nomura S, Utsunomiya H. Procalcitonin; mysterious protein in sepsis. J Basic Clinical Med. 2013; 2: 7-11, article.

Vijayan AL, Ravindran S, Saikant R, Lakshmi S, Kartik R, Manoj G. Procacitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017; 5: 51, CrossRef.

Ryoo SM, Han KS, Shin TG, Hwang SY, Chung SP, Hwang YJ. The usefulness of C-Reactive Protein and procalcitonin to predict prognosis in septic shock patients: a multicenter prospective registry-based observational study. Scientific Reports. 2019; 9: 6579, CrossRef.


Indexed by:






The Prodia Education and Research Institute